Mark to Market

85: Apollo Hospitals’ recovery from covid is encouraging, but its stock is pricey

Episode Summary

Apollo Hospitals Enterprises Ltd’s Q1FY21 revenue contraction is no surprise amid the pandemic. While the firm has done well on the cost front, the stock's pricey valuations seem to factor the brighter picture adequately. You can find more details by tuning in here

Episode Notes

Apollo Hospitals Enterprises Ltd’s Q1FY21 revenue contraction is no surprise amid the pandemic. While the firm has done well on the cost front, the stock's pricey valuations seem to factor the brighter picture adequately. You can find more details by tuning in here